DIGP - DigiPath, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1541
+0.0071 (+4.83%)
At close: 3:38PM EDT
Stock chart is not supported by your current browser
Previous Close0.1470
Open0.1500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1420 - 0.1541
52 Week Range0.1387 - 0.5900
Volume55,280
Avg. Volume66,457
Market Cap6.405M
Beta2.77
PE Ratio (TTM)N/A
EPS (TTM)-0.0450
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Digipath, Inc. CEO, Todd Denkin Interviewed on CEOLIVE.com

    LAS VEGAS, Sept. 20, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis industry, was selected by CEOLIVE Media Group for a comprehensive video interview with its President and CEO, Todd Denkin. Mr. Denkin had the opportunity to discuss Digipath's growth in Nevada and plans for expansion into Northern California and internationally, as well as the future of cannabis from a data perspective. Digipath Labs division has been finalizing ISO 17025 certification as this international standard has become mandatory for Nevada cannabis testing laboratories and in other jurisdictions around the country.

  • PR Newswire5 days ago

    Digipath Appoints Two New Directors to its Board

    Dr. Orser is the Chief Science Officer ("CSO") of Digipath's wholly owned subsidiary, Digipath Labs, Inc. As CSO of Digipath Labs since 2014, Cindy has created a replicable state-of-the-art cannabis-testing facility in Las Vegas, NV with validated standard operating procedures to ensure cannabis and cannabis-based products are safe once they reach the dispensary shelves. Dr. Orser is also leading Digipath's promotion of cannabis strain authentication, which combines chemoprofile data analytics with strain genotyping to distinguish cannabis drug type strains.

  • PR Newswire25 days ago

    Digipath's Chief Science Officer is featured in the current issue of The Analytical Scientist

    LAS VEGAS, Aug. 28, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis testing laboratory and media firm, is pleased to announce that its Chief Science Officer, Dr. Cindy Orser, is featured in the current issue of The Analytical Scientist, a publication that celebrates the people, the technology and the innovations that shape Analytical Science across all fields. In this article, entitled "Smashing the Grass Ceiling," Dr. Orser is one of seven women who are interviewed as breaking the proverbial "glass ceiling" in cannabis science by rising to the top in their perspective companies while other scientific fields still struggle with equity. Each female scientist shares their personal story of how they ended up entering cannabis, what is their passion that keeps them motivated in cannabis science and also their personal take on why there seems to be an equitable number of dedicated women scientists working on cannabis.

  • PR Newswire2 months ago

    Dr. Yunfeng Pan Joins Digipath Labs as Analytical Laboratory Director

    LAS VEGAS, July 12, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures. Dr. Pan brings to Digipath key skills in organizational leadership, project management, and complex problem solving from working in highly-regulated environments including those at Oak Ridge National Laboratory in Tennessee and Rio Valley Biofuels in El Paso, Texas where she served as laboratory compliance manager. Dr. Pan is also certified in OSHA Industry Safety and Health Training and will serve as Digipath Labs' chemical hygiene and safety officer.

  • PR Newswire3 months ago

    Digipath Labs Awarded Emerald Test Badges for Proficiency in Cannabis Potency and Contaminant Testing

    LAS VEGAS, June 20, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that it was awarded Emerald Badges for its performance in the Spring 2018 Emerald Test for proficiency in a variety of cannabis tests, including potency in oil, heavy metals, terpenes, microbial 1 (quantitative), microbial 2 (qualitative salmonella), shiga-toxin expressing E. coli (STEC), aspergillus mold, and mycotoxins. The Emerald Test™ is an Inter-Laboratory Comparison and Proficiency Test (ILC/PT) program for cannabis testing labs. It brings to the cannabis industry a well-established standard for testing in the environmental, food, pharmaceutical, water, and petrochemical testing industries.

  • PR Newswire3 months ago

    Digipath Labs Appoints Mr. Charlie Sturek as Quality Director

    LAS VEGAS, June 12, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that Mr. Charlie Sturek has been appointed as Quality Director for Digipath Labs. Mr. Sturek brings to the Digipath family nearly 20 years of quality management experience, from working first as a formulation chemist in the cosmetics industry and then as a quality manager for an emergency medical technician (EMT) department in a large hospital system in the Washington, D.C. area. Academically, Mr. Sturek is quite accomplished with degrees in biology and chemistry and an MBA from Stony Brook University.

  • PR Newswire4 months ago

    Mr. Rene Adler Joins Digipath Labs as Analytical Laboratory Manager

    LAS VEGAS, June 5, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that Mr. Rene Adler has joined its Las Vegas laboratory as its Analytical Laboratory Manager with oversight of the ISO 17025:2017 quality management system. Mr. Adler is an accomplished instrumental analytical chemist with 7 years of experience in the pesticide analysis of all fruits and vegetables entering Germany under stringent ISO regulations.

  • PR Newswire4 months ago

    Digipath Makes Progress with its Cannabis Testing Lab Joint Venture in Humboldt County, CA

    LAS VEGAS, May 17, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to provide this update on its previously announced joint venture to operate a cannabis testing laboratory in Humboldt County, CA. The cannabis lab will be well positioned to service all Humboldt County growers as well as growers located in neighboring Mendocino County.  This is significant, as Santa Barbara, Mendocino, Monterey, and Calaveras Counties account for 74% of the 1,256 cultivation licenses issued so far in California, with Humboldt County alone representing 20% of this total.

  • PR Newswire4 months ago

    Digipath Posts Revenue and EBITDA Results for Fiscal Second Quarter 2018

    LAS VEGAS , May 15, 2018 /PRNewswire/ --  Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • PR Newswire5 months ago

    Digipath's Chief Science Officer's Research on Cannabis Cultivar Classification Featured in Cannabis Science and Technology Magazine

    LAS VEGAS, April 17, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that research by its Chief Science Officer, Dr. Cindy Orser, published in the peer-reviewed scientific journal Natural Products Chemistry & Research, has been featured in Cannabis Science and Technology Magazine's first issue released March 2018. Dr. Orser's research focuses on the methodical classification of cultivars of the Cannabis sativa plant through broad genotypic and chemotypic analysis that includes not only cannabinoids but also terpenoids. Dr. Orser's research has found that unique terpenoid chemoprofile patterns exist and can be assigned to specific cultivars.

  • PR Newswire7 months ago

    Digipath Posts Record Revenue and EBITDA Results for Fiscal First Quarter 2018

    Company to Hold Conference Call to Review Results LAS VEGAS , Feb. 12, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing ...

  • PR Newswire8 months ago

    Digipath Labs Resumes Testing Operations Following Reinstatement of Nevada Licenses

    LAS VEGAS, Feb. 1, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced today that it has resumed cannabis testing operations following the reinstatement of the Medical Marijuana Registration Certificate and Marijuana Testing Facility License held by its wholly-owned subsidiary, Digipath Labs. This follows a full audit of the Company's lab facilities by the Nevada Department of Taxation, Marijuana Enforcement Division and the Department's approval of the Plan of Correction submitted by Digipath Labs. Digipath Labs also received its Clark County Business License allowing full operation in the county and the state.

  • PR Newswire8 months ago

    Digipath Hires Molecular Biologist|BioChemist Dr. Kimberly Ross, PhD, As Director of Quality Systems

    LAS VEGAS, Jan. 29, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced that it has hired Dr. Kimberly Ross, PhD, a seasoned molecular microbiologist and biochemist, as its Director of Quality Systems for its wholly owned subsidiary, Digipath Labs. Dr. Ross will lead the team responsible for implementing quality systems ensuring that all testing is conducted in compliance with Good Laboratory Practices, ISO-17205 standards and the regulations set by Nevada's Department of Taxation.  Dr. Ross will also work directly with Chief Science Officer, Dr. Cindy Orser, PhD, in overseeing the proper training of all new lab personnel. Dr. Ross brings to Digipath Labs experience as a Technical Director under the NELAC (National Environmental Laboratory Accreditation Program) Institute's rigorous accreditation program, where she was responsible for all aspects of data realization, client report generation, and laboratory operations within a compliant Quality Management System.

  • PR Newswire8 months ago

    Digipath To Submit a Plan of Correction to the State of Nevada's Department of Taxation, Marijuana Enforcement Division in Response to License Suspension

    LAS VEGAS , Jan. 22, 2018 /PRNewswire/ --  Digipath, Inc. (OTCQB: DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced that ...

  • PR Newswire8 months ago

    Digipath Labs Publishes Research on Application of Terpenoid Profiles in Cannabis Classification

    LAS VEGAS, Jan. 11, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, today announced that Dr. Cindy Orser, Chief Science Officer at Digipath Labs, recently published original research on the application of terpenoid chemoprofiles for cannabis classification in the peer-reviewed journal, Natural Products Chemistry & Research. This research furthers Digipath's scientific analysis on the importance of terpenoid data for growers and consumers. Dr. Cindy Orser commented, "We propose that three terpenoid cluster assignments account for the diversity of drug-type cannabis strains currently being grown in Nevada.

  • PR Newswire8 months ago

    Digipath to Hold Conference Call to Review Results for the Fiscal Year Ended September 30, 2017

    LAS VEGAS, Jan. 8, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, will be holding a conference call to review its recently released results for the quarter and fiscal year ended September 30, 2017. The conference call will take place at 4:15pm Eastern Time on Tuesday, January 9, 2018. On the call from Digipath will be Mr. Joseph Bianco, CEO, Mr. Todd Denkin, COO/President, Dr. Cindy Orser, Chief Science Officer, and Mr. Todd Peterson, CFO.

  • Digipath Labs Awarded the Emerald Test Badge for Potency and Pesticides Testing
    PR Newswire9 months ago

    Digipath Labs Awarded the Emerald Test Badge for Potency and Pesticides Testing

    LAS VEGAS, Jan. 5, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced that Digipath Labs, its wholly owned subsidiary, has been awarded Emerald Test Badges for Potency and Pesticides Testing.  Emerald Test recognition demonstrates the lab's proficiency and commitment to a higher standard of excellence in Cannabis Testing.  The Emerald Test Badge results provide a measure of assurance and reliability to the industry as a whole, and particularly to those who depend on testing lab's results for safety, health, and product performance. The Emerald Test® uses the standard Inter-laboratory Comparison Proficiency Testing (ILC/PT) program for evaluating how accurately and dependably testing labs perform, by comparing how well the lab measures blinded samples. ILC/PT programs are common in many testing industries, including environmental, food, pharmaceutical, water and petrochemical, providing a point of reference on how well the testing labs are performing individually and as a group.  Individual labs can use their ILC/PT results to either verify proficiency to their customers and state regulatory bodies or to point out analytical tests needing further validation effort.

  • PR Newswire9 months ago

    Digipath, Inc. Announces Record Results for the Fiscal Year Ended September 30, 2017

    LAS VEGAS , Jan. 2, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017
    Capital Cubelast year

    DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis DigiPath, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of DigiPath, Inc. – Internet of Things Inc. (ITT-CA) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.39 million, Net Earnings of USD -0.41 million. ... Read more (Read more...)

  • PR Newswirelast year

    Digipath, Inc. Enters into Joint Venture to Establish a Cannabis Testing Laboratory in California

    LAS VEGAS, Sept. 25, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis testing laboratory and media firm, is pleased to announce that it has entered into a joint venture with Mr. Don Ashley, an experienced real estate developer and cannabis entrepreneur, to establish and operate a cannabis testing laboratory in California. The joint venture, Humboldt Botanical, LLC, will conduct business under the name "Digipath Botanical Testing" and will launch Digipath's entry into the largest cannabis market in the United States. Pursuant to the joint venture agreement, Mr. Ashley will contribute up to $2 million to fund the build-out and equipping of the testing laboratory, while Digipath will be responsible for managing and supervising the day-to-day operations of the laboratory.  Digipath and Mr. Ashley will be entitled to receive 40% and 60%, respectively, of the joint venture's cash distributions, provided that until Mr. Ashley has received the return of his invested capital, distributions will made 75% to Mr. Ashley and 25% to Digipath.  Digipath has also provided the joint venture with a non-exclusive license to use its intellectual property in connection with the operation of the laboratory.